Artboard 51@300x

Cell Culture Dish summarizes Merck's IPEC webinar detailing the first-hand account of the complex process of regulatory agency drug product filing. The journey focuses on Merck's Ebola vaccine ERVEBO® and how it came to use Exbumin as an excipient.

Slide 3

We’re excited to have partnered with Pall Biotech to publish two new posters.
- The first looks at leveraging biomass probes with chemically defined, serum-free media to optimize transfection cell density.
- The second demonstrates the optimization of the chemically defined media to be used for lentivirus production at scale with HEK293t cells.

Slide 2

Emergence of a Blood-Free rHSA

Blood-Free rHSA will add safety, consistency, and enhanced performance to your cell culturing processes.
Our new Featured Report explores the many benefits of albumin and the various challenges that serum-derived proteins can create. Recombinant human serum albumin (rHSA), and specifically InVitria’s Blood-Free rHSA, overcomes these challenges, enhances performance, and is preferred by regulatory agencies.

Slide 2

Recent Advances of Chemical Definition of Cell Culture Media and Excipients for Virus and Viral Vector Manufacturing

Virus production is a critical step in cell and gene therapies and vaccine manufacture. Due to supply chain constraints, poor reproducibility, and safety concerns attributed to potential adventitious agents present in serum and serum-derived proteins, regulatory agencies have encouraged replacement of these components. Recombinant albumin and transferrin can successfully replace serum-derived proteins these applications.

Slide 1

NEW White Paper

Learn how recombinant transferrin enhances transient transfection and functional titer in viral vector production.

Slide 1

Product Catalog

We're Proud to Offer Our Updated Catalog for 2021.

Home page banner image

Performance. Defined.

The global leader in the production of blood-free components, supplements, and media to facilitate the approval of life changing medicines.

previous arrow
next arrow

InVitria Serum Free Cell Culture Media Components & Optimization

Product Applications

InVitria’s portfolio of chemically defined blood-free products enables development and production of novel therapeutics without use of any blood-derived components.

Click on the application of interest to find out how our products set the new standards in biologics manufacturing.

Learn More

Product Types

InVitria offers a suite of recombinant protein products, each of which is completely free of animal or human components and produced in a scalable, non-mammalian recombinant expression system at an ISO9001:2015 certified facility in Kansas, USA.

Learn More

Custom Media Formulation

InVitria is the leading brand of custom media formulations for gene therapy, cell therapy, vaccine & antibody production, and related culturing applications. Contact us to discuss your cell culture needs. Let us do the heavy lifting!

Learn More

  • Blood-Free & Chemically Defined
  • High Performance
  • Reliable Supply Chain
  • Faster Time to Market

2021 Product Catalog

Download InVitria’s Product Catalog to learn more about our:

  • Recombinant Proteins
  • Cell Culture Supplements
  • Blood-Free Cell Culture Media

Download PDF